Bank of Montreal’s Repros Therapeutics Inc. RPRX Stock Holding History

Bank of Montreal’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-57,200	Closed	-$570K	–	4472
2014 Q4	$570K	Hold	57,200	–	–	﹤0.01%	1999
2014 Q3	$566K	Hold	57,200	–	–	﹤0.01%	2022
2014 Q2	$990K	Sell	57,200 -10,000	-15%	-$163K	﹤0.01%	1756
2014 Q1	$1.19M	Buy	+67,200	New	+$1.3M	﹤0.01%	1575
2013 Q4	–	Sell	-7,900	Closed	-$212K	–	4179
2013 Q3	$212K	Buy	+7,900	New	+$169K	﹤0.01%	2219

Bank of Montreal's RPRX Position: Q1 2018 in Review

Bank of Montreal sold out of Repros Therapeutics Inc. (RPRX) in Q1 2018, closing a stake of 1,000 shares — an estimated $1K sold.

Bank of Montreal first reported a position in RPRX in Q2 2013 and held it in 19 quarters. The position peaked at $244K in Q1 2014. 1 fund tracked by Wall St. Rank holds RPRX as of Q1 2018.

Bank of Montreal reported no remaining Repros Therapeutics Inc. position as of Q1 2018 after selling out during the quarter.
Bank of Montreal sold 1,000 Repros Therapeutics Inc. shares in Q1 2018, an estimated $1K.
Bank of Montreal first reported a position in Repros Therapeutics Inc. in Q2 2013 and held it in 19 quarters.
Bank of Montreal's Repros Therapeutics Inc. position peaked at $244K in Q1 2014.
1 fund tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q1 2018.

Based on Bank of Montreal's 13F filing for Q1 2018, filed 13 Apr 2018.